FDA Clears Philips' Rembra Platform
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
The FDA has cleared Philips' Rembra platform, a ct imaging system. The clearance is expected to expand access to faster and more precise imaging, potentially streamlining workflows in diagnostic radiology and radiation therapy applications. However, reports vary on the specifics of the cleared system, with some mentioning a portable photon-counting ct scanner and others referencing different products altogether.
Full coverage
12345678